Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
ProSciento Inc. ( Site 0004), Chula Vista, California California Clinical Trials Medical Group managed by PAREXEL ( Site 0008), Glendale, California Velocity Clinical Research, Hallandale Beach ( Site 0010), Hallandale, Florida Jacksonville Center for Clinical Research ( Site 0002), Jacksonville, Florida Advanced Pharma CR, LLC ( Site 0001), Miami, Florida QPS Miami Research Associates ( Site 0005), South Miami, Florida AMR Lexington ( Site 0012), Lexington, Kentucky Alliance for Multispecialty Research, LLC ( Site 0013), Kansas City, Missouri Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0009), Springfield, Missouri AMR Clinical ( Site 0003), Knoxville, Tennessee ICON Early Phase Services ( Site 0006), San Antonio, Texas